Tag: Pionyr Immunotherapeutics

Gilead to acquire stake in cancer immunotherapy company Pionyr Immunotherapeutics

pharmanewsdaily- June 25, 2020

Gilead Sciences has agreed to acquire a stake of 49.9% in California-based cancer immunotherapy company Pionyr Immunotherapeutics, for $275 million. The pharma major has also ... Read More